 | • レポートコード：20QY06-01797 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ゴーシェ病のグローバル市場について種類別（酵素補充療法、基質還元療法）、用途別（非神経障害性ゴーシェ病、神経障害性ゴーシェ病）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ゴーシェ病市場の概要 ・世界の主要地域別ゴーシェ病市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のゴーシェ病市場規模2015-2026：種類別（酵素補充療法、基質還元療法） ・世界のゴーシェ病市場規模2015-2026：用途別（非神経障害性ゴーシェ病、神経障害性ゴーシェ病） ・ゴーシェ病の北米市場規模2015-2020 ・ゴーシェ病のヨーロッパ市場規模2015-2020 ・ゴーシェ病の中国市場規模2015-2020 ・ゴーシェ病の日本市場規模2015-2020 ・ゴーシェ病の東南アジア市場規模2015-2020 ・ゴーシェ病のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、Takeda、Actelion Pharma、Pfizer (Protalix)、ISU ABXIS） ・ゴーシェ病の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ゴーシェ病の市場動向・機会・課題 ・調査の結論 |
Gaucher disease is an inherited disorder that affects many of the body’s organs and tissues. The signs and symptoms of this condition vary widely among affected individuals.
The technical barriers of Gaucher disease industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Sanofi, Shire, Actelion Pharma, Pfizer, etc.
Market Analysis and Insights: Global Gaucher Disease Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gaucher Disease market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gaucher Disease industry.
Based on our recent survey, we have several different scenarios about the Gaucher Disease YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1721.7 million in 2019. The market size of Gaucher Disease will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Gaucher Disease Scope and Market Size
The global Gaucher Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gaucher Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Gaucher Disease market is segmented into
Enzyme Replacement Therapy
Substrate Reduction Therapy
Segment by Application, the Gaucher Disease market is segmented into
Non-neuronopathic Gaucher Disease
Neuronopathic Gaucher Disease
The Gaucher Disease market is analysed and market size information is provided by regions (countries). Segment by Application, the Gaucher Disease market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gaucher Disease Market Share Analysis
Gaucher Disease market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gaucher Disease business, the date to enter into the Gaucher Disease market, Gaucher Disease product introduction, recent developments, etc.
The major vendors covered:
Sanofi
Takeda
Actelion Pharma
Pfizer (Protalix)
ISU ABXIS
…
1 Gaucher Disease Market Overview
1.1 Gaucher Disease Product Scope
1.2 Gaucher Disease Segment by Type
1.2.1 Global Gaucher Disease Sales by Type (2020-2026)
1.2.2 Enzyme Replacement Therapy
1.2.3 Substrate Reduction Therapy
1.3 Gaucher Disease Segment by Application
1.3.1 Global Gaucher Disease Sales Comparison by Application (2020-2026)
1.3.2 Non-neuronopathic Gaucher Disease
1.3.3 Neuronopathic Gaucher Disease
1.4 Gaucher Disease Market Estimates and Forecasts (2015-2026)
1.4.1 Global Gaucher Disease Sales Growth Rate (2015-2026)
1.4.2 Global Gaucher Disease Revenue and Growth Rate (2015-2026)
1.4.3 Global Gaucher Disease Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Gaucher Disease Industry Impact
1.5.1 How the Covid-19 is Affecting the Gaucher Disease Industry
1.5.1.1 Gaucher Disease Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Gaucher Disease Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Gaucher Disease Players to Combat Covid-19 Impact
2 Gaucher Disease Estimate and Forecast by Region
2.1 Global Gaucher Disease Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Gaucher Disease Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Gaucher Disease Sales Market Share by Region (2015-2020)
2.2.2 Global Gaucher Disease Revenue Market Share by Region (2015-2020)
2.3 Global Gaucher Disease Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Gaucher Disease Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Gaucher Disease Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Gaucher Disease Estimates and Projections (2015-2026)
2.4.2 Europe Gaucher Disease Estimates and Projections (2015-2026)
2.4.3 China Gaucher Disease Estimates and Projections (2015-2026)
2.4.4 Japan Gaucher Disease Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Gaucher Disease Estimates and Projections (2015-2026)
2.4.6 India Gaucher Disease Estimates and Projections (2015-2026)
3 Global Gaucher Disease Competition Landscape by Players
3.1 Global Top Gaucher Disease Players by Sales (2015-2020)
3.2 Global Top Gaucher Disease Players by Revenue (2015-2020)
3.3 Global Gaucher Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher Disease as of 2019)
3.4 Global Gaucher Disease Average Price by Company (2015-2020)
3.5 Manufacturers Gaucher Disease Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Gaucher Disease Players (Opinion Leaders)
4 Global Gaucher Disease Market Size by Type
4.1 Global Gaucher Disease Historic Market Review by Type (2015-2020)
4.1.1 Global Gaucher Disease Sales Market Share by Type (2015-2020)
4.1.2 Global Gaucher Disease Revenue Market Share by Type (2015-2020)
4.1.3 Global Gaucher Disease Price by Type (2014-2020)
4.2 Global Gaucher Disease Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Gaucher Disease Sales Forecast by Type (2021-2026)
4.2.2 Global Gaucher Disease Revenue Forecast by Type (2021-2026)
4.2.3 Global Gaucher Disease Price Forecast by Type (2021-2026)
5 Global Gaucher Disease Market Size by Application
5.1 Global Gaucher Disease Historic Market Review by Application (2015-2020)
5.1.1 Global Gaucher Disease Sales Market Share by Application (2015-2020)
5.1.2 Global Gaucher Disease Revenue Market Share by Application (2015-2020)
5.1.3 Global Gaucher Disease Price by Application (2015-2020)
5.2 Global Gaucher Disease Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Gaucher Disease Sales Forecast by Application (2021-2026)
5.2.2 Global Gaucher Disease Revenue Forecast by Application (2021-2026)
5.2.3 Global Gaucher Disease Price Forecast by Application (2021-2026)
3 North America Gaucher Disease Market Facts & Figures
3.2 North America Gaucher Disease Sales Market Share by Company (2015-2020)
3.3 North America Gaucher Disease Sales Market Share by Type (2015-2020)
3.4 North America Gaucher Disease Sales Market Share by Application (2015-2020)
4 Europe Gaucher Disease Market Facts & Figures
4.2 Europe Gaucher Disease Sales Market Share by Company (2015-2020)
4.3 Europe Gaucher Disease Sales Market Share by Type (2015-2020)
4.4 Europe Gaucher Disease Sales Market Share by Application (2015-2020)
5 China Gaucher Disease Market Facts & Figures
5.2 China Gaucher Disease Sales Market Share by Company (2015-2020)
5.3 China Gaucher Disease Sales Market Share by Type (2015-2020)
5.4 China Gaucher Disease Sales Market Share by Application (2015-2020)
6 Japan Gaucher Disease Market Facts & Figures
6.2 Japan Gaucher Disease Sales Market Share by Company (2015-2020)
6.3 Japan Gaucher Disease Sales Market Share by Type (2015-2020)
6.4 Japan Gaucher Disease Sales Market Share by Application (2015-2020)
7 Southeast Asia Gaucher Disease Market Facts & Figures
7.2 Southeast Asia Gaucher Disease Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Gaucher Disease Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Gaucher Disease Sales Market Share by Application (2015-2020)
8 India Gaucher Disease Market Facts & Figures
8.2 India Gaucher Disease Sales Market Share by Company (2015-2020)
8.3 India Gaucher Disease Sales Market Share by Type (2015-2020)
8.4 India Gaucher Disease Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Gaucher Disease Business
12.1 Sanofi
12.1.1 Sanofi Gaucher Disease Corporation Information
12.1.2 Sanofi Gaucher Disease Business Overview and Total Revenue
12.1.3 Sanofi Gaucher Disease Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Gaucher Disease Products Offered
12.1.5 Sanofi Recent Development
12.2 Takeda
12.2.1 Takeda Gaucher Disease Corporation Information
12.2.2 Takeda Gaucher Disease Business Overview and Total Revenue
12.2.3 Takeda Gaucher Disease Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Takeda Gaucher Disease Products Offered
12.2.5 Takeda Recent Development
12.3 Actelion Pharma
12.3.1 Actelion Pharma Gaucher Disease Corporation Information
12.3.2 Actelion Pharma Gaucher Disease Business Overview and Total Revenue
12.3.3 Actelion Pharma Gaucher Disease Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Actelion Pharma Gaucher Disease Products Offered
12.3.5 Actelion Pharma Recent Development
12.4 Pfizer (Protalix)
12.4.1 Pfizer (Protalix) Gaucher Disease Corporation Information
12.4.2 Pfizer (Protalix) Gaucher Disease Business Overview and Total Revenue
12.4.3 Pfizer (Protalix) Gaucher Disease Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer (Protalix) Gaucher Disease Products Offered
12.4.5 Pfizer (Protalix) Recent Development
12.5 ISU ABXIS
12.5.1 ISU ABXIS Gaucher Disease Corporation Information
12.5.2 ISU ABXIS Gaucher Disease Business Overview and Total Revenue
12.5.3 ISU ABXIS Gaucher Disease Sales, Revenue and Gross Margin (2015-2020)
12.5.4 ISU ABXIS Gaucher Disease Products Offered
12.5.5 ISU ABXIS Recent Development
…
13 Gaucher Disease Manufacturing Cost Analysis
13.1 Gaucher Disease Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gaucher Disease
13.4 Gaucher Disease Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gaucher Disease Distributors List
14.3 Gaucher Disease Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Gaucher Disease Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Gaucher Disease Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Gaucher Disease Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Gaucher Disease Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Gaucher Disease Players to Combat Covid-19 Impact
Table 8. Global Market Gaucher Disease Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Gaucher Disease Sales (K Units) by Region (2015-2020)
Table 10. Global Gaucher Disease Sales Market Share by Region (2015-2020)
Table 11. Global Gaucher Disease Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Gaucher Disease Revenue Share by Region (2015-2020)
Table 13. Global Gaucher Disease Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Gaucher Disease Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Gaucher Disease Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Gaucher Disease Revenue Share Forecast by Region (2021-2026)
Table 17. Global Gaucher Disease (K Units) of Key Companies (2015-2020)
Table 18. Global Gaucher Disease Sales Share by Company (2015-2020)
Table 19. Global Gaucher Disease Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Gaucher Disease Revenue Share by Company (2015-2020)
Table 21. Global Gaucher Disease by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher Disease as of 2019)
Table 22. Global Gaucher Disease Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Gaucher Disease Manufacturing Sites and Area Served
Table 24. Manufacturers Gaucher Disease Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Gaucher Disease Players
Table 27. Global Gaucher Disease Sales (K Units) by Type (2015-2020)
Table 28. Global Gaucher Disease Sales Share by Type (2015-2020)
Table 29. Global Gaucher Disease Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Gaucher Disease Price (K Units) by Type (2015-2020)
Table 31. Global Gaucher Disease Sales Share by Type (2021-2026)
Table 32. Global Gaucher Disease Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Gaucher Disease Revenue Share by Type (2021-2026)
Table 34. Global Gaucher Disease Price (K Units) by Type (2021-2026)
Table 35. Global Gaucher Disease Sales (K Units) by Application (2015-2020)
Table 36. Global Gaucher Disease Sales Share by Application (2015-2020)
Table 37. Global Gaucher Disease Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Gaucher Disease Price (K Units) by Application (2015-2020)
Table 39. Global Gaucher Disease Sales (K Units) by Application (2021-2026)
Table 40. Global Gaucher Disease Sales Share by Application (2021-2026)
Table 41. Global Gaucher Disease Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Gaucher Disease Revenue Share by Application (2021-2026)
Table 43. Global Gaucher Disease Price (K Units) by Application (2021-2026)
Table 44. United States Gaucher Disease Sales (K Units) by Company (2015-2020)
Table 45. United States Gaucher Disease Sales Market Share by Company (2015-2020)
Table 46. United States Gaucher Disease Sales (K Units) by Type (2015-2020)
Table 47. United States Gaucher Disease Sales Market Share by Type (2015-2020)
Table 48. United States Gaucher Disease Sales (K Units) by Application (2015-2020)
Table 49. United States Gaucher Disease Sales Market Share by Application (2015-2020)
Table 50. Europe Gaucher Disease Sales (K Units) by Company (2015-2020)
Table 51. Europe Gaucher Disease Sales Market Share by Company (2015-2020)
Table 52. Europe Gaucher Disease Sales (K Units) by Type (2015-2020)
Table 53. Europe Gaucher Disease Sales Market Share by Type (2015-2020)
Table 54. Europe Gaucher Disease Sales (K Units) by Application (2015-2020)
Table 55. Europe Gaucher Disease Sales Market Share by Type (2015-2020)
Table 56. China Gaucher Disease Sales (K Units) by Company (2015-2020)
Table 57. China Gaucher Disease Sales Market Share by Company (2015-2020)
Table 58. China Gaucher Disease Sales (K Units) by Type (2015-2020)
Table 59. China Gaucher Disease Sales Market Share by Type (2015-2020)
Table 60. China Gaucher Disease Sales (K Units) by Application (2015-2020)
Table 61. China Gaucher Disease Sales Market Share by Application (2015-2020)
Table 62. Japan Gaucher Disease Sales (K Units) by Company (2015-2020)
Table 63. Japan Gaucher Disease Sales Market Share by Company (2015-2020)
Table 64. Japan Gaucher Disease Sales (K Units) by Type (2015-2020)
Table 65. Japan Gaucher Disease Sales Market Share by Type (2015-2020)
Table 66. Japan Gaucher Disease Sales (K Units) by Application (2015-2020)
Table 67. Japan Gaucher Disease Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Gaucher Disease Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Gaucher Disease Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Gaucher Disease Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Gaucher Disease Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Gaucher Disease Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Gaucher Disease Sales Market Share by Application (2015-2020)
Table 74. India Gaucher Disease Sales (K Units) by Company (2015-2020)
Table 75. India Gaucher Disease Sales Market Share by Company (2015-2020)
Table 76. India Gaucher Disease Sales (K Units) by Type (2015-2020)
Table 77. India Gaucher Disease Sales Market Share by Type (2015-2020)
Table 78. India Gaucher Disease Sales (K Units) by Application (2015-2020)
Table 79. India Gaucher Disease Sales Market Share by Application (2015-2020)
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sanofi Gaucher Disease Product
Table 84. Sanofi Recent Development
Table 85. Takeda Corporation Information
Table 86. Takeda Description and Business Overview
Table 87. Takeda Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Takeda Gaucher Disease Product
Table 89. Takeda Recent Development
Table 90. Actelion Pharma Corporation Information
Table 91. Actelion Pharma Description and Business Overview
Table 92. Actelion Pharma Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Actelion Pharma Gaucher Disease Product
Table 94. Actelion Pharma Recent Development
Table 95. Pfizer (Protalix) Corporation Information
Table 96. Pfizer (Protalix) Description and Business Overview
Table 97. Pfizer (Protalix) Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Pfizer (Protalix) Gaucher Disease Product
Table 99. Pfizer (Protalix) Recent Development
Table . ISU ABXIS Corporation Information
Table . ISU ABXIS Description and Business Overview
Table . ISU ABXIS Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . ISU ABXIS Gaucher Disease Product
Table . ISU ABXIS Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Gaucher Disease Distributors List
Table 108. Gaucher Disease Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Gaucher Disease Product Picture
Figure 2. Global Gaucher Disease Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Gaucher Disease Market Share by Application in 2020 & 2026
Figure 6. Non-neuronopathic Gaucher Disease Examples
Figure 7. Neuronopathic Gaucher Disease Examples
Figure 8. Global Gaucher Disease Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Gaucher Disease Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Gaucher Disease Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Gaucher Disease Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Gaucher Disease Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Gaucher Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Gaucher Disease Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Gaucher Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Gaucher Disease Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Gaucher Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Gaucher Disease Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Gaucher Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Gaucher Disease Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Gaucher Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Gaucher Disease Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Gaucher Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Gaucher Disease Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Gaucher Disease Players Market Share by Revenue in Gaucher Disease 2015 & 2019
Figure 26. Gaucher Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Gaucher Disease Revenue Share by Type (2015-2020)
Figure 28. Global Gaucher Disease Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Gaucher Disease Revenue Share by Application (2015-2020)
Figure 30. Global Gaucher Disease Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Gaucher Disease Sales Market Share by Type in 2019
Figure 32. United States Gaucher Disease Sales Market Share by Type in 2019
Figure 33. Europe Gaucher Disease Sales Market Share by Company in 2019
Figure 34. Europe Gaucher Disease Sales Market Share by Type in 2019
Figure 35. Europe Gaucher Disease Sales Market Share by Application in 2019
Figure 36. China Gaucher Disease Sales Market Share by Company in 2019
Figure 37. China Gaucher Disease Sales Market Share by Type in 2019
Figure 38. China Gaucher Disease Sales Market Share by Application in 2019
Figure 39. Japan Gaucher Disease Sales Market Share by Company in 2019
Figure 40. Japan Gaucher Disease Sales Market Share by Type in 2019
Figure 41. Japan Gaucher Disease Sales Market Share by Application in 2019
Figure 42. Southeast Asia Gaucher Disease Sales Market Share by Company in 2019
Figure 43. Southeast Asia Gaucher Disease Sales Market Share by Type in 2019
Figure 44. Southeast Asia Gaucher Disease Sales Market Share by Application in 2019
Figure 45. India Gaucher Disease Sales Market Share by Company in 2019
Figure 46. India Gaucher Disease Sales Market Share by Type in 2019
Figure 47. India Gaucher Disease Sales Market Share by Application in 2019
Figure 48. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Actelion Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Pfizer (Protalix) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. ISU ABXIS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Gaucher Disease
Figure 55. Manufacturing Process Analysis of Gaucher Disease
Figure 56. Gaucher Disease Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
酵素補充療法の世界市場レポート2020 Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme. The classification of enzyme replacement therapy includes injectable…- ライム病ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Lyme Disease Vaccine Market The global Lyme Disease Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Lyme Disease Vaccine Scope and Market Size The global Lyme …
- ハンチントン病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Huntington’s Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 29.6% in the forecast period of 2020 to 2025 and will expected to reach USD 509 million by 2025, from USD 180.4 million in 2019. The Huntingt…
- アルツハイマー病治療薬の世界市場レポート2020 A recently published report by QY Research titled Global Alzheimer's Disease Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides ac…
- 転移性骨疾患治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Bone Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastatic …